Researchers at Case Western Reserve University School of Medicine have uncovered the
mechanism1 that enables the
enzyme2 Lecithin: retinol acyltransferase (LRAT) to store vitamin A--a process that is indispensable for vision. "Without this information, our knowledge was
inadequate3 to understand the
molecular4 mechanisms5 of blindness caused by mutations in the enzyme," said Marcin Golczak, assistant professor of pharmacology at Case Western Reserve and an author of the study.
The researchers hope the new information will be used to design small
molecule7 therapies for degenerative eye diseases. The same
enzymatic9 activity of LRAT that allows specific cells to absorb vitamin A can be used to transport small molecule drugs to the eye. These drugs would accumulate in eye tissue, lowering the effective dose and reducing risk of systemic side effects.
Their work is published in the journal Nature Chemical Biology.
Golczak, medical student Avery E. Sears, pharmacology
instructor10 Philip D. Kiser and pharmacology chair Krzysztof Palczewski compared the function of LRAT and closely related
enzymes11 that belong to N1pC/P60 family. They found that small variations in the protein sequences determine the substrate specificity--the substances on which the enzymes act--and thus govern
physiological12 functions of these enzymes.
LRAT regulates
cellular13 uptake of vitamin A by
helping14 convert it to a usable form called retinyl ester. Retinyl ester is essential for our eyes to function. Consequently, lack of LRAT leads to vitamin A deficiency and blindness.
Unlike LRAT, a close relative, HRAS-like
tumor15 suppressor 3, referred to as HRASLS3, does not process vitamin A, but is involved in regulation of triglycerides
breakdown16 in white fat cells. Triglycerides provide an energy source for body tissues. But excess accumulation leads to
obesity17 and related
metabolic18 syndrome19, increasing the risk of heart disease,
diabetes20 and other health problems.
Mice lacking HRASLS3 gained no weight when fed high-calorie diets--even mice that were
genetically21 engineered to be
obese22 and lacking leptin, the
hormone23 that signals mammals when they've eaten enough food.
The functions of these enzymes were known, but until now, there has been little understood about what enables the close relatives to go about their different jobs. The researchers looked at how LRAT is different from the rest of its protein family.
"Evolution of enzymatic activities via
gene8 duplication,
mutation6 and selection has led to the present diversity of metabolic capabilities," Golczak said. "Our studies explain what
modification24 in the cellular enzymatic
machinery25 enables vertebrates to
efficiently26 take up and store excess vitamin A."